-3-tert-butoxycarbony-2-(4-anisyl)-4- phenyl-5- oxazolidinium acidum carboxylicum

(4s,5r) ​​-3-tert-butoxycarbony-2-(4-anisyl)-4- phenyl-5- oxazolidini carboxylici adhibetur ut medium Docetaxel.
Docetaxel apta est curationi carcinomatis localis progressi vel metastatici pectoris.Docetaxel apta est curationi cancri localis progressae vel metastaticae non-parvae pulmonis pulmonis, etiam post defectionem cisplatinae chemotherapyae fundatae.